REPROCELL Unveils New Master Cell Bank Service for Clinical iPSCs REPROCELL has launched a new service for the production of induced pluripotent stem cells, ensuring compliance with FDA Good Manufacturing Practices. This service enhances efficiency for cellular therapy developers.

REPROCELL Unveils New Master Cell Bank Service for Clinical iPSCs #USA #Beltsville #iPSC #REPROCELL #StemRNA